Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly Wows ADA Crowd With Obesity Data Across Three-Drug Incretin Portfolio
Weight Loss Of Up To 24.2% With ‘Triple G’ Retatrutide
Jun 27 2023
•
By
Mandy Jackson
Lilly presented data at ADA on three obesity drugs • Source: Shutterstock
More from Clinical Trials
More from R&D